Advanced search
Start date
Betweenand
Conteúdos relacionados
(Reference retrieved automatically from Web of Science through information on FAPESP grant and its corresponding number as mentioned in the publication by the authors.)

Study of anticancer properties of proanthocyanidin-rich cinnamon extract in combination with Bifidobacterium animalis subsp. lactis BLC1 and resistance of these free and co-encapsulated materials under in vitro simulated gastrointestinal conditions

Full text
Author(s):
Holkem, Augusto Tasch [1, 2] ; Favaro-Trindade, Carmen Silvia [1] ; Lacroix, Monique [2]
Total Authors: 3
Affiliation:
[1] Univ Sao Paulo, Fac Zootecnia & Engn Alimentos, Ave Duque de Caxias Norte 225, BR-13635900 Pirassununga, SP - Brazil
[2] Inst Nutr & Funct Foods INAF, Canadian Irradiat Ctr, INRS Armand Frappier Hlth & Biotechnol Ctr, Res Lab Sci Appl Food, 531 Blvd Prairies, Laval, PQ H7V 1B7 - Canada
Total Affiliations: 2
Document type: Journal article
Source: Food Research International; v. 134, AUG 2020.
Web of Science Citations: 0
Abstract

Bifidobacterium animalis subsp. lactis (BLC1) and proanthocyanidin-rich cinnamon extract (PRCE) have many beneficial health properties. However, they are very sensitive materials; co-encapsulation is one alternative to protect them. Therefore, the objective of this work was to evaluate the anticancer properties of free PRCE and in combination with BLC1 and the resistance of these free and co-encapsulated materials under in vitro simulated gastrointestinal conditions. In terms of anticancer proprieties, PRCE had an IC50 value close to 30 mg extract/mL for Hepa 1c1c7 and HT-29 cells and resulted in a significantly higher percentage (p <= 0.05) of total apoptotic and necrotic cells compared to treatment in combination with BLC1 (PRCE + BLC1), with values above 31.66% in both cells. For the quinone reductase (QR) assay, there was a significant increase only for PRCE + BLC1 treatment, with a fold induction of 5.11 +/- 0.56 for HT-29. The resistance of the encapsulated materials was greater than for the free form after 240 min of simulated gastrointestinal conditions. The combination of these materials in a microcapsule is advantageous because it protects them under gastrointestinal conditions, allowing them to be released into the intestine and act in the early stages of colon cancer. (AU)

FAPESP's process: 18/05315-3 - Chemo-preventive properties of extracts from blueberries, jabuticabas and cinnamon isolated or combined with probiotics
Grantee:Augusto Tasch Holkem
Support Opportunities: Scholarships abroad - Research Internship - Doctorate
FAPESP's process: 15/19375-0 - Coencapsulation of probiotics and proanthocyanidin-rich extract obtained from cinnamon (Cinnamomum zeylanicum Blume)
Grantee:Augusto Tasch Holkem
Support Opportunities: Scholarships in Brazil - Doctorate